ENDPOINTS

Cidara's preventive influenza biologic is effective in Phase 2b trial

Cidara Therapeutics’ long-acting antiviral biologic effectively prevented seasonal flu infections in a mid-stage trial, the biotech said Monday. Its shares {$CDTX} were up 95% in early trade on the Nasdaq. ...

Jun 23, 2025 - 15:40
 0
Cidara's preventive influenza biologic is effective in Phase 2b trial
Cidara Therapeutics’ long-acting antiviral biologic effectively prevented seasonal flu infections in a mid-stage trial, the biotech said Monday. Its shares {$CDTX} were up 95% in early trade on the Nasdaq. ...
Read More

Tags:

Previous Article

The light triad: Expert explains psychology's answer to our darkest fears about ...

Next Article

NASA Fosters Innovative, Far-Out Tech for the Future of Aerospace

Related Posts

HHS urges against reviving Chamber of Commerce’s IRA suit

HHS urges against reviving Chamber of Commerce’s IRA suit

Jun 11, 2025  0

Blackstone's GRIN inks epilepsy licensing deal with Angelini, closes $140M Series D

Blackstone's GRIN inks epilepsy licensing deal with Ang...

May 27, 2025  0

FDA gives AbbVie accelerated approval for antibody-drug conjugate in lung cancer

FDA gives AbbVie accelerated approval for antibody-drug...

May 14, 2025  0